Joan Perell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Joan perell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Joan Perell Today - Breaking & Trending Today

Sanifit Seals Booming Acquisition Year for Spanish Life Sciences

The takeover of the Spanish firm Sanifit by Vifor Pharma in Switzerland marks a high point for the life sciences sector in Spain, which has seen a burst of acquisitions this year. ....

United Kingdom , Comunidad Autonoma De Cataluna , Palo Biopharma , Pablo Cironi , Joan Perell , Vifor Pharma , Life Sciences Investments At Caixa Capital Risc , Life Sciences Investments , Caixa Capital Risc , Managing Partner , Ysios Capital , Origo Biopharma , Agomab Therapeutics , Biotech Foods , Mosaic Biomedical ,

Vifor Pharma Acquires Sanifit Therapeutics

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

Vifor Pharma , Joan Perell , Abbas Hussain , Swiss Stock Exchange , Vifor Pharma Group , European Medicines Agency , Drug Administration , Swiss Exchange , Fresenius Medical Care , Sanifit Therapeutics , Chief Executive Officer , Peripheral Artery Disease , European Medicines , Pharma Group , Vifor Fresenius Medical Care Renal Pharma ,

Vifor Pharma Doubles Down on Kidney Disease with New Acquisitions

Switzerland-based Vifor Pharma is acquiring Spain’s Sanifit Therapeutics and another Swiss company, Inositec. ....

Mattias Ivarsson , Vifor Pharma , Joan Perell , Abbas Hussain , University Of The Balearic , European Medicines Agency , Drug Administration , Sanifit Therapeutics , Balearic Islands , Swiss Based Inositec , Swiss Francs , Ifor Pharma Doubles Down On Kidney Disease With New Acquisitions ,

Caixa Capital Risc leads sale of Sanifit Therapeutics to Vifor Pharma with upfront payment of €205M

Barcelona, Spain, November 23, 2021 – Caixa Capital Risc, the venture capital subsidiary of CriteriaCaixa, today announces the sale of its portfolio company Sanifit Therapeutics to Vifor Pharma, a global pharmaceutical company that aims to become an industry leader in iron deficiency, nephrology and cardio-renal the. ....

Comunidad Autonoma De Cataluna , Pablo Cironi , Joan Perell , Vifor Pharma , Boehringer Ingelheim , Malta Life Sciences , Centre For The Development Of Industrial Technology , Swiss Stock Exchange , Swiss Exchange , University Of The Balearic , Vifor Pharma Group , Fresenius Medical Care , Caixa Capital Risc , Sanifit Therapeutics , Balearic Islands , Calcific Uremic Arteriolopathy , Peripheral Artery Disease , Capital Risc , Caixa Capital , Caixa Capital Risk , Criteria Bio Ventures , Northern Biologics , Foreign Direct Investment , Uremic Arteriolopathy , End Stage Renal Disease , Cardiovascular Calcification ,

Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology

Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology ....

Joan Perell , Vifor Pharma , Abbas Hussain , Malta Life Sciences , Centre For The Development Of Industrial Technology , Swiss Stock Exchange , Drug Administration , Swiss Exchange , Vifor Pharma Group , University Of The Balearic , European Medicines Agency , Fresenius Medical Care , Sanifit Therapeutics , European Medicines , Chief Executive Officer , Pharma Group , Vifor Fresenius Medical Care Renal Pharma , Balearic Islands , Caixa Capital Risc , Ysios Capital , Lundbeckfonden Ventures , Forbion Capital Partners , Gilde Healthcare , Andera Partners , Columbus Venture Partners , Baxter Ventures ,